Literature DB >> 28123610

Bladder cancer, ESMO 2016.

Alan So1.   

Abstract

Entities:  

Year:  2016        PMID： 28123610      PMCID： PMC5167577          DOI： 10.5489/cuaj.4281

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  1 in total

1.  Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.

Authors:  Arjun V Balar; Matthew D Galsky; Jonathan E Rosenberg; Thomas Powles; Daniel P Petrylak; Joaquim Bellmunt; Yohann Loriot; Andrea Necchi; Jean Hoffman-Censits; Jose Luis Perez-Gracia; Nancy A Dawson; Michiel S van der Heijden; Robert Dreicer; Sandy Srinivas; Margitta M Retz; Richard W Joseph; Alexandra Drakaki; Ulka N Vaishampayan; Srikala S Sridhar; David I Quinn; Ignacio Durán; David R Shaffer; Bernhard J Eigl; Petros D Grivas; Evan Y Yu; Shi Li; Edward E Kadel; Zachary Boyd; Richard Bourgon; Priti S Hegde; Sanjeev Mariathasan; AnnChristine Thåström; Oyewale O Abidoye; Gregg D Fine; Dean F Bajorin
Journal:  Lancet       Date:  2016-12-08       Impact factor: 79.321
  1 in total
  4 in total

1.  Identification of Biomarkers Correlated with the TNM Staging and Overall Survival of Patients with Bladder Cancer.

Authors:  Sheng Li; Xiaoping Liu; Tongzu Liu; Xiangyu Meng; Xiaohong Yin; Cheng Fang; Di Huang; Yue Cao; Hong Weng; Xiantao Zeng; Xinghuan Wang
Journal:  Front Physiol       Date:  2017-11-28       Impact factor: 4.566

2.  Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer.

Authors:  Kui Cao; Tianjiao Ma; Xiaodong Ling; Mingdong Liu; Xiangyu Jiang; Keru Ma; Jinhong Zhu; Jianqun Ma
Journal:  Ann Transl Med       Date:  2021-10

3.  The Clinical Relevance of Fragile Histidine Triad Protein (FHIT) in Patients with Bladder Cancer.

Authors:  Xiao-Ping Liu; Xiao-Hong Yin; Xin-Hui Yan; Xian-Tao Zeng; Xing-Huan Wang
Journal:  Med Sci Monit       Date:  2018-05-12

4.  DHCR24 predicts poor clinicopathological features of patients with bladder cancer: A STROBE-compliant study.

Authors:  Xiao-Ping Liu; Xiao-Hong Yin; Xiang-Yu Meng; Xin-Hui Yan; Yue Cao; Xian-Tao Zeng; Xing-Huan Wang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.